SJS Investment Consulting’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.7K Buy
821
+166
+25% +$8.08K ﹤0.01% 508
2026
Q1
$28.1K Sell
655
-23
-3% -$989 ﹤0.01% 575
2025
Q4
$29.7K Buy
678
+645
+1,955% +$26.7K ﹤0.01% 519
2025
Q3
$1.36K Hold
33
﹤0.01% 919
2025
Q2
$1.46K Sell
33
-16
-33% -$640 ﹤0.01% 682
2025
Q1
$1.81K Buy
49
+4
+9% +$143 ﹤0.01% 769
2024
Q4
$1.5K Sell
45
-9
-17% -$292 ﹤0.01% 846
2024
Q3
$1.4K Hold
54
﹤0.01% 946
2024
Q2
$1.21K Hold
54
﹤0.01% 957
2024
Q1
$1.28K Hold
54
﹤0.01% 933
2023
Q4
$1.3K Sell
54
-2
-4% -$43 ﹤0.01% 842
2023
Q3
$1.22K Buy
56
+2
+4% +$42 ﹤0.01% 850
2023
Q2
$1.03K Sell
54
-1
-2% -$19 ﹤0.01% 894
2023
Q1
$1.07K Buy
55
+5
+10% +$87 ﹤0.01% 865
2022
Q4
$802 Buy
50
+16
+47% +$261 ﹤0.01% 1049
2022
Q3
$1K Buy
+34
New +$657 ﹤0.01% 705
2022
Q1
$0 Buy
+8
New +$156 ﹤0.01% 892

Other funds holding EXEL

SJS Investment Consulting's EXEL Position: Q2 2026 in Review

SJS Investment Consulting increased its Exelixis (EXEL) stake by 25% in Q2 2026, buying an estimated $8.08K and bringing the position to 821 shares worth $44.7K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

SJS Investment Consulting first reported a position in EXEL in Q1 2022 and has held it in 17 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • SJS Investment Consulting held 821 shares of Exelixis worth $44.7K as of Q2 2026.
  • SJS Investment Consulting bought 166 Exelixis shares in Q2 2026, an estimated $8.08K.
  • Exelixis made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #508 holding.
  • SJS Investment Consulting first reported a position in Exelixis in Q1 2022 and has held it in 17 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.